Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Burkitt Lymphoma 11Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Biphenotypic, Acute 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Waldenstrom Macroglobulinemia 2Smoldering Multiple Myeloma 2Neoplasm Metastasis 2Lymphoma, Mantle-Cell 2Lymphoma 2Lung Neoplasms 2Leukemia 2Immunoglobulin Light-chain Amyloidosis 2Down Syndrome 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm, Residual 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Plasma Cell 1

Interventions

Therapeutics 2Exercise 2enzalutamide 1dexamethasone acetate 1dexamethasone 21-phosphate 1darolutamide 1auricularum 1apalutamide 1Therapeutic Touch 1Testosterone 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sildenafil Citrate 1Relaxation Therapy 1Radiotherapy 1Quality of Life 1Methods 1Gels 1Exercise Test 1Electroacupuncture 1Educational Status 1Early Intervention, Educational 1Dexamethasone 1Counseling 1Consolidation Chemotherapy 1Chemoradiotherapy 1Calcium Dobesilate 1Autogenic Training 1Acupressure 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Calcium Dobesilate × 90 days × Clear all
NCT02491632 2026-03-18

Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Active not recruiting
90 enrolled 13 charts

Fatigue, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡